Dear Colleague,
Thank you for taking part in this survey on the management of the clinically node-negative (cN0) neck in sinonasal malignancies. Sinonasal malignancies are rare and biologically heterogeneous, and the role of elective neck treatment in cN0 disease remains controversial and largely unaddressed by prospective evidence.
This survey aims to characterize current European practice, identify the factors that drive decision-making, and highlight areas of consensus and genuine equipoise that could form the basis for future prospective studies or consensus guidelines.
The survey takes approximately 5-10 minutes to complete. All responses will be handled confidentially and reported only in aggregate/anonymized form.
We greatly appreciate your expertise and your time.
On behalf of the Young-CEORL - Head and neck group
Christina Sauter, MD
